Nicolas Tsapis' publications:

31      R. Díaz-López, N. Tsapis, M. Santin, S.L. Bridal, V. Nicolas, D. Jaillard, D. Libong, P. Chaminade, V. Marsaud, C. Vauthier and E. Fattal. The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. Biomaterials, 31(7): 1723-1731(2010). DOI:10.1016/j.biomaterials.2009.11.044

30     R. Díaz-López, N. Tsapis and E. Fattal. Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and (19)F-MRI. Pharm. Res., 27(1): 1-16 (2010). DOI10.1007/s11095-009-0001-5

29      P. Fritsch, A. L. Serandour, O. Gremy, B. Le Gall, G. Phan, N. Tsapis, E. Fattal, H. Benech, J. R. Deverre, N. Blanchin, L. Grappin, E. Blanchardon, B. Breustedt, and J. L. Poncy. Modelling Pu/Am decorporation by DTPA. Radioprotection 44: 431-446 (2009).

28       E. Pisani, C. Ringard, V. Nicolas, E. Raphaël, V. Rosilio,  L. Moine, E. Fattal and N. Tsapis. Tuning microcapsules surface morphology using blends of homo and copolymers of PLGA and PLGA-PEG. Soft Matter, 5(16): 3054-3060 (2009).  DOI 10.1039/b902042j

27       M. Khoder, N. Tsapis, H. Huguet, M. Besnard, C. Gueutin and E. Fattal. Removal of ciprofloxacin in simulated digestive media by activated charcoal entrapped within zinc pectinate beads. Int. J. Pharm. 379(2):251-259 (2009).  DOI 10.1016/j.ijpharm.2009.05.035 

26       J. Bourgeois, M. Lalanne, L.-A. Pierson, V. Marsaud, V. Nicolas, N. Tsapis, R. Ball, D. Stanimirovic, P. Couvreur, K. Andrieux. Formulation of glycerolipidic prodrugs into PEGylated liposomes for brain delivery. J. Drug Del. Sci. Tech., 19 (1) : 61-66 (2009).

25       P. Fritsch, A.L. Sérandour,  O. Grémy, G. Phan, N. Tsapis, M.C. Abram, D. Renault, E. Fattal, H. Benech, J.R. Deverre and J.L. Poncy. Simplified structure of a new model to describe urinary excretion of Pu after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments. Radiation Research, 171 (6): 674–686 (2009). doi: 10.1667/RR1530.1

24       R. Díaz-López, N. Tsapis, D. Libong, P. Chaminade, C. Connan, M. M. Chehimi, R. Berti, N. Taulier, W. Urbach, V. Nicolas, and E. Fattal. Phospholipid-decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials, 30 (8): 1462-1472 (2009). doi:10.1016/j.biomaterials.2008.11.032 

23       G. Marty and N. Tsapis. Monitoring the buckling threshold of drying colloidal droplets using water-ethanol mixtures. European Physical Journal E, 27: 213-219 (2008).
DOI 10.1140/epje/i2008-10375-6

22       E. Pisani, E. Fattal, J. Paris, C. Ringard, V. Rosilio and N. Tsapis. Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: influence of polymer adsorption at the dichloromethane-water interface. Journal of Colloid and Interface Science, 326: 66–71 (2008). doi:10.1016/j.jcis.2008.07.013  

21       R. Díaz-López, D. Libong, N. Tsapis, E. Fattal and P. Chaminade. Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a Charged Aerosol Detector. Journal of Pharmaceutical and Biomedical Analysis, 48: 702–707 (2008). doi:10.1016/j.jpba.2008.06.027

20       E. Pisani, N. Tsapis, B. Galaz, M. Santin, R. Berti, N. Taulier, E. Kurtisovski, O. Lucidarme, M. Ourevitch, B.T. Doan, J. C. Beloeil, B. Gillet, W. Urbach, S. L. Bridal and E. Fattal. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging. Advanced Functional Materials, 18: 2963–2971 (2008).

19       B. San Román, J. M. Irache, S. Gómez, N. Tsapis, C. Gamazo, S. Espuelas. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology. European Journal of Pharmaceutics and Biopharmaceutics, 70 (1): 98-108 (2008). doi:10.1016/j.ejpb.2008.03.015  

18       C. Gómez Gaete, N. Tsapis, L. Silva, C. Bourgaux, M. Besnard, A. Bochot, E. Fattal. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone. European Journal of Pharmaceutics and Biopharmaceutics, 70 (1): 116-126 (2008). doi:10.1016/j.ejpb.2008.04.013  

17       S. Bourgeois, N. Tsapis, H. Honnas, A. Andremont, M. Shakweh, M. Besnard, E. Fattal. Colonic delivery of beta-lactamases does not affect amoxicillin pharmacokinetics in rats. J Pharm Sci. 97(5):1853-1863 (2008). doi:10.1002/jps.21115

16       C. Gómez Gaete, E. Fattal, L. Silva, M. Besnard, N. Tsapis. Dexamethasone acetate encapsulation into Trojan particles. Journal of Controlled Release, 28(1): 41-49 (2008). doi:10.1016/j.jconrel.2008.02.008    

15       C. Gómez Gaete, N. Tsapis, L. Silva, C. Bourgaux, E. Fattal. Morphology, structure and supramolecular organization of hybrid 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine-Hyaluronic acid microparticles prepared by spray-drying. European Journal of Pharmaceutical Sciences, 34(1):12-21 (2008). doi:10.1016/j.ejps.2008.02.003 

14       A.L. Serandour, N. Tsapis, C. Gervelas, G. Grillon, M. Frechou, J.R. Deverre, H. Benech, E. Fattal, P. Fritsch, J.L. Poncy. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms. Radiat Prot Dosimetry. 127: 472-476 (2007). doi:10.1093/rpd/ncm300

13       S. Pechine, C.Janoir, H. Boureau, A. Gleizes, N. Tsapis, S. Hoys, E. Fattal, A. Collignon. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine. 25(20), 3946-3954  (2007). doi:10.1016/j.vaccine.2007.02.055 

12       C. Gervelas, A.-L. Serandour, S. Geiger , G. Grillon, P. Fritsch, C. Taulelle, B. Le Gall, H. Benech, J.-R. Deverre, E. Fattal and  N. Tsapis. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium. J. Control. Release 118, 78–86 (2007). doi:10.1016/j.jconrel.2006.11.027

11       C. Gómez-Gaete, N. Tsapis, M. Besnard, A. Bochot and E. Fattal. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int. J. Pharm. 331, 153–159 (2007).  doi:10.1016/j.ijpharm.2006.11.028

10       A.L. Gomes dos Santos, A. Bochot, A. Doyle, N. Tsapis, J. Siepmann, F. Siepmann, J. Schmaler, M. Besnard, F. Behar-Cohen and E. Fattal. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. J. Control. Release 112 (3): 369-381 (2006). doi:10.1016/j.jconrel.2006.02.010 

9          E. Pisani, N. Tsapis, J. Paris, V. Nicolas, L. Cattel and E. Fattal. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir 22 (9): 4397-4402 (2006).  DOI: 10.1021/la0601455

8          A. L. Gomes dos Santos, A. Bochot, N. Tsapis, F. Artzner, R. A. Bejjani, B. Thillaye-Goldenberg, Y. de Kozak, E. Fattal and F. Behar-Cohen. Oligonucleotides-polyethylenimine complexes targeting retinal cells: Structural analysis and application to anti-TGF-beta 2 therapy. Pharm. Res. 23(4): 770-781 (2006). doi:10.1007/s11095-006-9748-0

7          N. Tsapis, E. R. Dufresne, S. S. Sinha, C. S. Riera, J.W. Hutchinson, L. Mahadevan, and D. A. Weitz. Onset of Buckling in Drying Droplets of Colloidal Suspensions. Phys. Rev. Lett. 94 018302 (2005). doi:10.1103/PhysRevLett.94.018302

6          N. Tsapis, D. Bennett, K O’Driscoll, K. Shea, M. M. Lipp, K. Fu, R. W. Clarke, D. Deaver, D. Yamins, J. Wright, C. A. Peloquin, D. A. Weitz and D. A. Edwards. Direct lung delivery of para-aminosalicylic acid by aerosol particles. Tuberculosis 83, 379 (2003). doi:10.1016/j.tube.2003.08.016 

5          N. Tsapis, D. Bennett, B. Jackson, D. A. Weitz and D. A. Edwards. Trojan Particles: Large Porous carriers of nanoparticles for drug delivery. Proc. Natl Acad. Sci. USA, 99, 12001-12005 (2002).  doi: 10.1073/pnas.182233999

4          N. Tsapis, R. Ober, A. Chaffotte, D. Warschawski, John Everett, John Kauffman, P. Kahn, M. Waks and W. Urbach. Modification of the elastic constants of a peptide-decorated lamellar phase. Langmuir 18, 4384 (2002). DOI: 10.1021/la015745c

3         N. Tsapis, F. Reiss-Husson, R. Ober, M. Genest, R. S. Hodges and W. Urbach. Self diffusion and properties of a membrane protein, the Rubrivivax gelatinosus LH2 complex, incorporated in a monoolein cubic phase. Biophysical Journal 81, 1613 (2001). doi:10.1016/S0006-3495(01)75815-8

2          N. Tsapis, R. Ober and W. Urbach. Dramatic rigidification of a peptide-decorated lamellar phase. Physical Review E 63, 041903 (2001).  doi: 10.1103/PhysRevE.63.041903

1          N. Tsapis, R. Ober and W. Urbach. Modifications of elastic constants by charge addition to a nonionic lamellar phase. Langmuir 16, 2968-2974 (2000). DOI: 10.1021/la9908541